Franziska R. Zientek

Leipzig, SN 04103, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Music engages the phasic dopaminergic D1-receptor system in humans: a PET-fMRI study using [11C]SCH23390.

Music engages the phasic dopaminergic D1-receptor system in humans: a PET-fMRI study using [11C]SCH23390.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 05, 2025

Cholinergic network modulation in disinhibited eating behavior.

Cholinergic network modulation in disinhibited eating behavior.

Journal: Communications biology

Published: April 24, 2025

The relationship between α4β2-nicotinic acetylcholine receptor availability and brain arousal regulation as assessed by 2-[18F]F-A85380 PET and EEG following nicotine cessation in male individuals with nicotine dependence.

The relationship between α4β2-nicotinic acetylcholine receptor availability and brain arousal regulation as assessed by 2-[18F]F-A85380 PET and EEG following nicotine cessation in male individuals with nicotine dependence.

Journal: Psychiatry research. Neuroimaging

Published: January 13, 2025

Abnormalities of iron homeostasis and the dopaminergic system in Tourette syndrome revealed by 7T MRI and PET.

Abnormalities of iron homeostasis and the dopaminergic system in Tourette syndrome revealed by 7T MRI and PET.

Journal: Brain communications

Published: August 02, 2024

Noradrenergic control of neurobehavior in human binge-eating disorder and obesity (NOBEAD): A smartphone-supported behavioral emotion regulation intervention study protocol integrating molecular brain imaging.

Noradrenergic control of neurobehavior in human binge-eating disorder and obesity (NOBEAD): A smartphone-supported behavioral emotion regulation intervention study protocol integrating molecular brain imaging.

Journal: The International journal of eating disorders

Published: December 02, 2022

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity.

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity.

Journal: Brain sciences

Published: July 25, 2022

Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study.

Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study.

Journal: Biological psychiatry

Published: June 29, 2022

Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

Journal: Brain sciences

Published: June 03, 2022

HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls.

HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls.

Journal: Brain sciences

Published: May 13, 2022

Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity.

Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity.

Journal: Scientific reports

Published: June 12, 2020

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study.

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 03, 2020

In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine - A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET).

In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine - A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET).

Journal: Frontiers in pharmacology

Published: February 28, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026